Cerebral Angiography Comprehensive Study by Type (Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Conventional Angiography, Digital Subtraction Angiography (DSA), Catheter angiography, Coronary angiography), Application (Hospitals and Surgical Centers, Diagnostics Centers, Academic and Research Institutes), Gender (Male, Female) Players and Region - Global Market Outlook to 2026

Cerebral Angiography Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Cerebral Angiography Market Overview:
Cerebral Angiography also called intra-arterial digital subtraction angiography is used to detect abnormalities like Arteriovenous, Malformations and aneurysms from the images of blood vessels around the brain. These abnormalities may lead to bleeding in the brain or a stroke. To perform this test, a contrast medium is injected into the blood and the catheter is inserted into the artery which helps the x-ray to create a clearer picture. This procedure takes usually from one to three hours.

Growth Drivers
  • Increasing Prevalence of Coronary Diseases
  • Increasing Demand of Minimally Invasive Surgeries

Roadblocks
  • High Costs Associated with the Cerebral Angiography
  • Potential Risk during the Procedure like Damage to Blood Vessel, Blood Clots around Catheter Tips

Opportunities
  • Government Initiatives to Improve Health Care Infrastructure in Developing Countries

Challenges
  • Fluctuating Upgradation of Angiography Devices
  • Lack of Awareness among the People


Competitive Landscape:
Cerebral Angiography has various players in the market and is focusing on continuous research and development in cerebral angiography technological advancement. They are also increasing investment for the same, and planning on strategic activities like mergers, partnerships, and collaborations. This will helps them expand and maintain their competencies edge and serve better to patients.
Some of the key players profiled in the report are GE Healthcare (United States), Siemens Healthineers (Germany), Samsung Medison (South Korea), St. Jude Medical Inc. (United States), Abbott Laboratories (United States), Shimadzu Corporation (Japan), Hitachi Medical Corporation (Japan), Bayer Ag (Germany), Allengers (India) and OSCOR Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like Degania Silicone Ltd. (Israel), CathRx Ltd. (Australia), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), TERUMO Corporation (Japan) and Koninklijke Philips N.V. (Netherlands). Analyst at AMA Research see United States Players to retain maximum share of Global Cerebral Angiography market by 2026. Considering Market by Gender, the sub-segment i.e. Male will boost the Cerebral Angiography market.

Latest Market Insights:
On 9th January 2018, Hitachi Healthcare Americas Corporation, a wholly-owned subsidiary of Hitachi, Ltd. and a leading provider of medical imaging modalities to hospital and ambulatory clients nationwide, announced that it has entered into an agreement to acquire VidiStar, LLC, a Greenville, SC-based company focused on reinventing how doctors review and report on diagnostic exams to drive productivity, portability, and improved communication and clinical decision making.

On 28th February 2019, schema view, the worldwide leader in advanced imaging for stroke care and research, announced RAPID ANGIO, a complete neuroimaging solution for the angiography suite that integrates iSchemaView’s RAPID software with syngo DynaCT Multiphase from Siemens Healthineers.

What Can be Explored with the Cerebral Angiography Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Cerebral Angiography Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Cerebral Angiography
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cerebral Angiography market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cerebral Angiography market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organizations.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Magnetic Resonance Angiography (MRA)
  • Computed Tomography Angiography (CTA)
  • Conventional Angiography
  • Digital Subtraction Angiography (DSA)
  • Catheter angiography
  • Coronary angiography
By Application
  • Hospitals and Surgical Centers
  • Diagnostics Centers
  • Academic and Research Institutes
By Gender
  • Male
  • Female

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Coronary Diseases
      • 3.2.2. Increasing Demand of Minimally Invasive Surgeries
    • 3.3. Market Challenges
      • 3.3.1. Fluctuating Upgradation of Angiography Devices
      • 3.3.2. Lack of Awareness among the People
    • 3.4. Market Trends
      • 3.4.1. Continuous Technological Advancements are Being Done
      • 3.4.2. Rising Investments in Research and Developments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Cerebral Angiography, by Type, Application, Gender and Region (value) (2015-2020)
    • 5.1. Introduction
  • 6. Cerebral Angiography: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. GE Healthcare (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Siemens Healthineers (Germany)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Samsung Medison (South Korea)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. St. Jude Medical Inc. (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Abbott Laboratories (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Shimadzu Corporation (Japan)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Hitachi Medical Corporation (Japan)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Bayer Ag (Germany)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Allengers (India)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. OSCOR Inc. (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Cerebral Angiography Sale, by Type, Application, Gender and Region (value) (2021-2026)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 5. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 6. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 7. Siemens Healthineers (Germany) Revenue: by Geography 2020
  • Figure 8. Samsung Medison (South Korea) Revenue, Net Income and Gross profit
  • Figure 9. Samsung Medison (South Korea) Revenue: by Geography 2020
  • Figure 10. St. Jude Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 11. St. Jude Medical Inc. (United States) Revenue: by Geography 2020
  • Figure 12. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 13. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 14. Shimadzu Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 15. Shimadzu Corporation (Japan) Revenue: by Geography 2020
  • Figure 16. Hitachi Medical Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 17. Hitachi Medical Corporation (Japan) Revenue: by Geography 2020
  • Figure 18. Bayer Ag (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Bayer Ag (Germany) Revenue: by Geography 2020
  • Figure 20. Allengers (India) Revenue, Net Income and Gross profit
  • Figure 21. Allengers (India) Revenue: by Geography 2020
  • Figure 22. OSCOR Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. OSCOR Inc. (United States) Revenue: by Geography 2020
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • Siemens Healthineers (Germany)
  • Samsung Medison (South Korea)
  • St. Jude Medical Inc. (United States)
  • Abbott Laboratories (United States)
  • Shimadzu Corporation (Japan)
  • Hitachi Medical Corporation (Japan)
  • Bayer Ag (Germany)
  • Allengers (India)
  • OSCOR Inc. (United States)
Additional players considered in the study are as follows:
Degania Silicone Ltd. (Israel) , CathRx Ltd. (Australia) , Toshiba Medical Systems Corporation (Japan) , Hitachi Medical Corporation (Japan) , TERUMO Corporation (Japan) , Koninklijke Philips N.V. (Netherlands)
Select User Access Type

Key Highlights of Report


Jul 2021 216 Pages 50 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Cerebral Angiography market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Cerebral Angiography market are GE Healthcare (United States), Siemens Healthineers (Germany), Samsung Medison (South Korea), St. Jude Medical Inc. (United States), Abbott Laboratories (United States), Shimadzu Corporation (Japan), Hitachi Medical Corporation (Japan), Bayer Ag (Germany), Allengers (India) and OSCOR Inc. (United States), to name a few.
"Continuous Technological Advancements are Being Done " is seen as one of major influencing trends for Cerebral Angiography Market during projected period 2020-2026.

Know More About Global Cerebral Angiography Market Report?